Innate ends Ph1b in peripheral T cell lymphoma; Layoffs at NextCure
Plus, news about Evommune, Maruho and Nouscom:
Innate Pharma gives up on Phase 1b trial for cancer drug: The company was evaluating lacutamab as a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
